Plans to double its manufacturing footprint to bolster the growth
The pharma division’s domestic business generated turnover of Rs. 219.85 crore for the last financial year
Domestic business was up 41.9% YoY and 27.7% QoQ
Veteran pharma leader brings 33+ years of experience to drive operational excellence in formulation business
Operational leverage kicked in during the quarter, with adjusted EBITDA rising 21% year-on-year to Rs 147 crore
Call it one of the most striking turnarounds in the Indian pharma sector this fiscal year
The company recorded revenue of Rs. 1,065 crore in the third quarter of FY26
With global certification in place, the Ambernath site expands Supriya’s footprint beyond APIs into high-margin formulations
The company reported revenue from operations at Rs. 6,573.7 crore, up 6 per cent YoY
Subscribe To Our Newsletter & Stay Updated
